All articles by Strategic Intelligence

Big tech meets biotech: Recursion and the AI gold rush in pharma

The use of AI in drug discovery and development has been recognised, explored, and implemented throughout the last decade, with…
Microplastics: the silent threat

Microplastics, tiny plastic bits less than five millimetres in size, come from breaking down larger plastics and are now everywhere.…
The promising future of regenerative medicine

Regenerative medicine aims to repair, augment, replace or regenerate damaged or diseased human cells, tissues, genes, organs or metabolic processes,…
The healthcare sector must change its industrial refrigeration methods to reduce its emissions

Industrial refrigeration is key to the healthcare industry, but it contributes massively to its emissions. Several companies are starting to…
Centenarians – unlocking the secrets of living to 100

The concept of extremely long life, popularised in films like Highlander, may seem like pure fiction, however; researchers are actively…

Ultra-processed food is causing a boom for obesity drug Ozempic

The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs. One example…
For pharma companies, the possibilities of green chemistry are huge

"Green" or “sustainable" chemistry has been gaining momentum since the 1990s. It is based on 12 principles, which include decreasing…
Digital twins: A new path to personalised medicine

Many healthcare professionals have long seen the potential of personalised medicine to revolutionise the industry by understanding patients’ unique needs…
How AI can help tackle the challenges of precision and personalised medicine

The classic one-size-fits-all method of treatment is changing to tailored ones that consider individual differences in genetics, lifestyle, and environment.…
How personalised medicine can revolutionise contraception

Across the world, there are 1.9 billion women of reproductive age. According to a 2021 study from the World Health…